AXGN AxoGen, Inc.
Healthcare$41.45+1.34%ClosedMarket Cap: $2.20B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
8.74
P/S
9.26
EV/EBITDA
376.22
DCF Value
$-21.95
FCF Yield
0.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
75.0%
Operating Margin
-3.8%
Net Margin
-13.2%
ROE
-20.7%
ROA
-10.9%
ROIC
-3.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $61.5M | 75.2% | $-2.8M | $-19.6M | $— | — |
| Q4 null | $59.9M | 74.1% | $-9.8M | $-13.2M | $— | — |
| FY null | $225.2M | 74.3% | $-7.8M | $-15.7M | $— | — |
| Q3 null | $60.1M | 76.6% | $1.9M | $708.0K | $— | — |
| Q2 null | $56.7M | 74.2% | $1.7M | $579.0K | $— | — |
| Q1 null | $48.6M | 71.9% | $-1.7M | $-3.8M | $— | — |
| Q4 null | $49.4M | 76.1% | $2.0M | $450.0K | $— | — |
| FY null | $187.3M | 75.8% | $-3.3M | $-10.0M | $— | — |
| Q3 null | $48.6M | 74.9% | $-316.0K | $-1.9M | $— | — |
| Q2 null | $47.9M | 73.8% | $-428.0K | $-1.9M | $— | — |
| Q1 null | $41.4M | 78.8% | $-4.6M | $-6.6M | $— | — |
| Q4 2023 | $42.9M | 78.7% | $-3.2M | $-3.9M | $-0.09 | — |